The European Commission’s EU Funding & Me mobile app offers a simple and flexible way to explore funding opportunities and follow your projects - anytime, anywhere.
Filter by
News (13)
HERA, in close cooperation with HaDEA, is preparing three new funding actions to enhance the EU’s readiness for health emergencies - from investigational vaccine reserves for filoviruses to PPE manufacturing capacity and innovative solutions for API stockpiling and rapid medicine production.
A new EU call for tenders aims to speed up the development of innovative therapeutics for infectious diseases through a competitive, phased approach under Pre-Commercial Procurement.
We’re excited to launch the new call for applications to join the ICF, HERA’s platform for collaboration across the full lifecycle of medical countermeasures — from R&D to manufacturing, deployment, and uptake.
On 4 September, HERA published two new calls for proposals under EU4Health to strengthen Europe’s preparedness against health crises. These calls aim to accelerate the development of innovative diagnostic tools for vector-borne diseases and support the advancement of medical countermeasures.
The survey targets authorities and project developers across 14 EU countries to gather insights on how to improve industrial permitting processes.
Discover HERA's strategic orientations for 2025 in the newly released Work Plan.
Three HERA calls under EU4Health are now open for proposals: Next-Generation Influenza Vaccines, AST PoC Medical Device (AMR), & Mpox Vaccine Clinical Trial
HERA review: Taking stock to reinforce health security in the EU
HaDEA has just published a Prior Information Notice for two upcoming HERA-funded call for tenders under EU4Health.